semaglutide 1.25 mg approved exercise Wegovy 0.25 mg/0.5 mL pre-filled

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist a medication that mimics the action of GLP-1, a naturally occurring hormone produced in the gut in response to eating

The guidelines have explicitly recommended glucagon-like peptide-1 receptor agonists (GLP-1RAs) with proven cardiovascular (CV) benefits as one of the top two preferred options for adjunctive therapy in T2DM

Qsymia has become a second-line option, recommended when GLP-1 medications are not tolerated, not accessible, or contraindicated

Purity is confirmed by high-performance liquid chromatography (HPLC) and identity by mass spectrometry (MS)

Both the thigh and abdomen are approved injection sites with good absorption